GlassScriptPhysician profile
Bradley Len Icard
NPI 1720320898
$298,649.10
in general payments reported to CMS, 2019-2025
43 companies · $185K in 2025
The $185K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $1,975 · 2021: $4,481 · 2022: $8,972 · 2023: $56K · 2024: $41K · 2025: $185K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $131K · Education: $71K · Travel and Lodging: $37K · Consulting Fee: $26K · Food and Beverage: $18K · Gift: $63.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $131,200.00 |
| Education | $70,995.85 |
| Travel and Lodging | $36,591.12 |
| Consulting Fee | $26,120.00 |
| Food and Beverage | $17,670.34 |
| Gift | $63.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $256,786.48 | 2021-2025 | Da Vinci Sp, Da Vinci Surgical System, Ion |
| Siemens Medical Solutions USA, INC. | $17,472.82 | 2025 | Cios Spin |
| Insmed, INC. | $9,576.64 | 2023-2025 | Arikayce, Brinsupri |
| Astrazeneca Pharmaceuticals LP | $6,551.05 | 2019-2025 | Tagrisso, Datroway, Tezspire |
| Abbvie INC. | $1,655.74 | 2022-2025 | |
| Olympus America INC. | $1,515.42 | 2025 | |
| Glaxosmithkline, LLC. | $825.70 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Galvanize Therapeutics, INC | $481.95 | 2024-2025 | Aliya System |
| Genzyme Corporation | $360.88 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $309.79 | 2021-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $261.68 | 2019-2024 | Opsumit, Uptravi |
| Grifols USA, LLC | $246.58 | 2022-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.94 | 2019-2025 | Ofev, Jascayd |
| Genentech USA, INC. | $223.53 | 2019 | |
| Amgen INC. | $208.84 | 2021-2025 | Lumakras, Tezspire, Tavneos |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $187.10 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| United Therapeutics Corporation | $176.69 | 2020-2025 | Tyvaso, Tyvaso |
| Novartis Pharmaceuticals Corporation | $162.17 | 2022-2024 | |
| Abiomed | $143.68 | 2024 | Impella |
| Takeda Pharmaceuticals U.S.A., INC. | $143.36 | 2023-2025 | Glassia |
| Medtronic, INC. | $141.50 | 2025 | Illumisite |
| Mylan Specialty L.P. | $140.06 | 2019-2024 | Yupelri |
| Verona Pharma, INC. | $127.14 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $103.87 | 2020-2021 | |
| Viatris Specialty LLC | $66.47 | 2025 | Yupelri |
| Inogen, INC. | $64.34 | 2022-2024 | |
| Harmony Biosciences LLC | $59.89 | 2025 | |
| Ani Pharmaceuticals, INC. | $43.99 | 2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $43.52 | 2020-2022 | |
| Pfizer INC. | $43.27 | 2023-2025 | |
| Shionogi INC | $41.20 | 2023 | Fetroja |
| Noah Medical Corporation | $40.91 | 2025 | Galaxy |
| Teva Pharmaceuticals USA, INC. | $40.09 | 2022 | |
| La Jolla Pharmaceutical Company | $29.30 | 2019-2020 | |
| Baxter Healthcare | $28.08 | 2025 | Hillrom - Vest System Model 105 Home Care |
| E.R. Squibb & Sons, L.L.C. | $17.73 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $17.66 | 2025 | Lumryz |
| Philips North America LLC | $16.76 | 2023 | |
| Portola Pharmaceuticals, LLC | $16.56 | 2019 | |
| Ambu INC. | $13.24 | 2023 | |
| Idorsia Pharmaceuticals US INC | $12.72 | 2023 | Quviviq |
| Alexion Pharmaceuticals, INC. | $11.61 | 2019 | |
| Allergan, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Icard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.